These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34951355)

  • 41. Toll-like receptor signalling as a cannabinoid target.
    Cui Sun M; Otálora-Alcaraz A; Prenderville JA; Downer EJ
    Biochem Pharmacol; 2024 Apr; 222():116082. PubMed ID: 38438052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoids: new promising agents in the treatment of neurological diseases.
    Giacoppo S; Mandolino G; Galuppo M; Bramanti P; Mazzon E
    Molecules; 2014 Nov; 19(11):18781-816. PubMed ID: 25407719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potential of the endocannabinoid system in the brain.
    Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
    Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
    Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
    Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases.
    Milando R; Friedman A
    Am J Clin Dermatol; 2019 Apr; 20(2):167-180. PubMed ID: 30542832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation.
    Mastinu A; Premoli M; Ferrari-Toninelli G; Tambaro S; Maccarinelli G; Memo M; Bonini SA
    Horm Mol Biol Clin Investig; 2018 Mar; 36(2):. PubMed ID: 29601300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
    O'Brien M; McDougall JJ
    Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
    Cristino L; Bisogno T; Di Marzo V
    Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endogenous cannabinoids revisited: a biochemistry perspective.
    Fonseca BM; Costa MA; Almada M; Correia-da-Silva G; Teixeira NA
    Prostaglandins Other Lipid Mediat; 2013; 102-103():13-30. PubMed ID: 23474290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the Role of the Endocannabinoid System in Axon Guidance: A Literature Review.
    Uthayakumaran K; Sunil M; Ratcliffe EM
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):12-20. PubMed ID: 38174983
    [No Abstract]   [Full Text] [Related]  

  • 54. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cannabis and cannabinoids: pharmacology and therapeutic potential.
    Śmiarowska M; Białecka M; Machoy-Mokrzyńska A
    Neurol Neurochir Pol; 2022; 56(1):4-13. PubMed ID: 35133644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from
    Nigro E; Formato M; Crescente G; Daniele A
    Molecules; 2021 May; 26(9):. PubMed ID: 34063214
    [No Abstract]   [Full Text] [Related]  

  • 57. Cannabinoids as multifaceted compounds.
    Persia D; Mangiavacchi F; Marcotullio MC; Rosati O
    Phytochemistry; 2023 Aug; 212():113718. PubMed ID: 37196772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabis for inflammatory bowel disease.
    Naftali T; Mechulam R; Lev LB; Konikoff FM
    Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease.
    Han QW; Yuan YH; Chen NH
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109745. PubMed ID: 31442553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The endocannabinoid system as a target for the treatment of neurodegenerative disease.
    Scotter EL; Abood ME; Glass M
    Br J Pharmacol; 2010 Jun; 160(3):480-98. PubMed ID: 20590559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.